Article Text
Statistics from Altmetric.com
Commentary on: De Giorgi R, De Crescenzo F, Cowen PJ, Harmer CJ, Cipriani A. Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study. BMC Med. 2023 Nov 7;21(1):424. doi: 10.1186/s12916-023-03138-5.
Implications for practice and research
Providers should encourage antidepressant use with statins for depression that is comorbid with physical conditions.
Research can clarify which population subgroups taking both medications demonstrate improved outcomes.
Context
Depression affects more than 350 million people worldwide.1 Even though guidelines support using antidepressants to treat moderate and severe depression, nearly 50% of people do not respond to antidepressants2 and 25% discontinue them.3 Studies suggest that adding statins to antidepressants can improve antidepressant adherence, but these studies have been underpowered to test outcomes.4
Methods
De Giorgi and colleagues used …
Footnotes
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.